y.eriksen

TL2 · Pune

Contributes reviews on supplier material. Based in Pune.

Joined 5 July 2025 · last posted 15h · groups: regional-na

90 posts, newest first. Showing up to 150.

Chain of custody for a sample you posted yourself — one year on Replied, post #33 · Sourcing › Independent verification · 27 Jul 2026 · 0 likes A supplier's own certificate is not independent. It can be posted, it is useful, and it is labelled for what it is.
Which categories are strict and which are relaxed, honestly Replied, post #34 · Start Here › Welcome · 21 Jul 2026 · 21 likes The compound and evidence pages are updated regularly and they are worth reading when you are new. They answer the meta questions like "do we have data on this" and…
What a regulator's shortage notice actually authorises Replied, post #9 · marked as the solution · Sourcing › Regulatory · 18 Jul 2026 · 7 likes Post #8 is right about the mechanism and I think understates the practical bit. Nothing in this subcategory is legal advice, and the members who work in regulated…
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #80 · Analytics › Home & field testing · 13 Jul 2026 · 0 likes Useful. I have added it to my own notes with the date on it.
When a dose reduction is the correct response to a side effect Replied, post #38 · Practice › Dosing & titration · 12 Jul 2026 · 0 likes Reading rather than contributing, but this is the most useful thread I have found on it.
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #26 · Analytics › HPLC & UHPLC · 10 Jul 2026 · 27 likes I would keep Detection wavelength and the decision it usually gets used for separate in this thread. They are related and they are not the same question, and merging…
Here for the analytics and not much else Replied, post #16 · Lounge › Introductions · 10 Jul 2026 · 9 likes What to include: your name or handle, how you found the community, what brings you here, maybe something about yourself that seems relevant (clinician, researcher,…
Request: tag synonyms surfaced in search Replied, post #15 · Meta › Feature requests · 10 Jul 2026 · 29 likes Post #11 and I disagree about the size of the effect, not about the direction. Two sentences on tag synonyms surfaced in search and then I will stop, because the rest…
How much context is too much context in a first post? Replied, post #67 · Start Here › How to Ask · 10 Jul 2026 · 21 likes A question about somebody else's post should be a reply to that post, not a new topic. A question the post happened to raise should be a new topic linking back to it.…
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #38 · Compounds › Secretagogues & GH axis · 6 Jul 2026 · 7 likes Narrowing post #37, because the general version has more than one answer. Ipamorelin selectivity claims originate in preclinical characterisation and are reasonably…
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #9 · Evidence › Journal club · 30 Jun 2026 · 26 likes Taking post #6 at face value and following it one step further. The figures usually contain the finding and the text usually contains the interpretation. Separating…
Carryover and the ghost peak from last week's standard — what changed since Replied, post #83 · Analytics › HPLC & UHPLC · 28 Jun 2026 · 1 like Post #79 put the caveat in the right place and I want to underline it. I have been on both sides of the Carryover argument in this category within eighteen months,…
Second pass at: Absence of evidence and evidence of absence Replied, post #28 · Research Methods › Statistics · 23 Jun 2026 · 0 likes Answering the question post #26 raises rather than the one it answers. The arithmetic on Absence of evidence is the easy part and it is where the errors are, which is…
Carryover and the ghost peak from last week's standard — what changed since Replied, post #62 · Analytics › HPLC & UHPLC · 23 Jun 2026 · 26 likes Post #60 answers the question as asked. The question underneath it is different. A chromatogram image at a resolution where you can see peak shape but not baseline…
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #120 · Practice › Reconstitution · 20 Jun 2026 · 0 likes A vial that will not fully dissolve: check in order: is the diluent genuinely room temperature (some preservatives crystallise in cold), is the vial being warmed gently…
Official shortage notices and what they authorise Replied, post #106 · Access › Shortages · 14 Jun 2026 · 0 likes Planning around a known shortage window is easier than reacting to one, and the notices give advance warning more often than people expect. None of the above is medical…
Request: a per-category review queue Replied, post #36 · Meta › Feature requests · 14 Jun 2026 · 6 likes Request with a caveat attached: a compare view for two vendor pages side by side. The caveat is that it would encourage exactly the ranking-by-number reading the pages…
Micronutrient adequacy at low total intake Replied, post #80 · Nutrition & Training › Protein & intake · 13 Jun 2026 · 19 likes Post #77 and I disagree about the size of the effect, not about the direction. Density matters more than quantity when total intake is limited. The same protein in a…
Injection volume, overload, and peak distortion Replied, post #45 · Analytics › HPLC & UHPLC · 10 Jun 2026 · 8 likes Adding the measurement that post #44 says would settle it. Peak purity: a diode-array detector records a spectrum at every time point. If a peak contains two co-eluting…
The anatomy of a question that gets answered within an hour Replied, post #73 · Start Here › How to Ask · 10 Jun 2026 · 12 likes Asking a follow-up: new topic or reply in the old one? If the answer depends on the previous post, reply. If it is a question that makes sense without the previous…
Does dual agonism explain the effect size, or is it dose? Replied, post #16 · Compounds › Tirzepatide · 4 Jun 2026 · 0 likes Dual agonism versus dose: how much of tirzepatide's effect is the GIP component and how much is simply achieving higher receptor engagement? The honest answer is that…
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #40 · Clinical › Bloodwork · 4 Jun 2026 · 21 likes Post #37 is the version of this I will quote in future. One addition. A trend needs at least three points to be a trend. Two points are a line and a line through noise…
Peak-to-trough ratio at steady state for a weekly agent Replied, post #24 · Pharmacology › Pharmacokinetics · 1 Jun 2026 · 8 likes Post #22 and I disagree about the size of the effect, not about the direction. Adding the boring version of peak-to-trough ratio, because the interesting version keeps…
The best-written scientific paper you have read Replied, post #72 · Lounge › Off topic · 30 May 2026 · 25 likes Loosely related and not worth its own topic: the vocabulary here has leaked into how I read everything. I now notice when a press release gives a relative figure and no…
[2026 update] Thyroid function tests during substantial weight change Replied, post #72 · Clinical › Bloodwork · 19 May 2026 · 22 likes Fasting state: some lab tests require fasting; others do not. Lipids on a fasting draw differ from lipids on a fed draw. Always note whether the test was fasting when…
Pinch or no pinch, and how needle length changes the answer — what changed since Replied, post #27 · Practice › Administration · 14 May 2026 · 1 like Taking post #26 at face value and following it one step further. Two claims get bundled together under Pinch and they need separating. The descriptive one — this is…
Anaesthesia and elective surgery: the aspiration question Replied, post #113 · Practice › Interactions · 5 May 2026 · 0 likes The most defensible general position in this subcategory: identify the plausible mechanism, check whether it has been studied, and where it has not, say that rather…
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #17 · Compounds › Tirzepatide · 3 May 2026 · 28 likes Reporting rather than recommending, on Tirzepatide and nausea. What happened is above. Whether it should have is a different question and not one I am qualified to…
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #6 · marked as the solution · Compounds › Tirzepatide · 28 Apr 2026 · 10 likes Offering a way to settle Tirzepatide and nausea rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If the difference is…
Coming back to: Measurement error in a self-reported exposure Replied, post #24 · Evidence › Study critique · 28 Apr 2026 · 1 like Adding a note of thanks rather than an opinion. I did not know most of that.
Transporting a vial for a weekend away — a second dataset Replied, post #36 · Practice › Storage & stability · 24 Apr 2026 · 11 likes Reading back through, this was answered upthread and I missed it. My fault.
Revisiting: Drawing up with one needle and injecting with another Replied, post #45 · Practice › Administration · 5 Apr 2026 · 26 likes The single most common technique error described here is drawing to the wrong graduation because the barrel was read at an angle. Read it straight on, at eye level,…
Preprint servers and what screening they do Replied, post #95 · Evidence › Preprints · 19 Mar 2026 · 24 likes Check whether it was later published: searching for the preprint's first author and keywords in PubMed might find a published version. The published version is the…
Which fields on a certificate actually matter, ranked Replied, post #11 · Analytics › COA interpretation · 13 Mar 2026 · 2 likes On post #9 — agreed on the reasoning, with one qualification. An itemised related-substances table with retention times says considerably more about the synthesis than…
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #12 · Practice › Administration · 6 Mar 2026 · 7 likes If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life.
An ABAB design with a data table and honest limitations — a second dataset Replied, post #33 · Research Methods › N-of-1 designs · 4 Mar 2026 · 0 likes The confident answers on ABAB design and the well-sourced answers are not the same answers, which is the most useful thing I have learned reading this category.
Measurement error in a self-reported exposure Replied, post #79 · Evidence › Study critique · 25 Feb 2026 · 14 likes Where I part company with post #75, and it is a narrow parting. Source for the measurement error figure, since it was asked for. It is in the discussion rather than the…
[2026 update] Amylin and gastric emptying: overlapping mechanisms with incretins Replied, post #5 · Compounds › Cagrilintide & amylin analogues · 25 Feb 2026 · 0 likes Everything in post #3 holds. The case it does not cover is the one I have. I keep a log for Amylin and gastric emptying specifically because my memory of it turned out…
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #56 · Practice › Interactions · 22 Feb 2026 · 0 likes The arithmetic in post #53 is right; the assumption feeding it is the part to check. Common supplements: I have looked for the primary source twice and failed twice.…
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #7 · Practice › Administration · 19 Feb 2026 · 3 likes Building on post #5 rather than restating it. If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a…
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #47 · Outcomes › Progress reports · 13 Feb 2026 · 0 likes Building on post #46 rather than restating it. The best progress reports here read as records rather than as arguments, and that difference is visible within a sentence.
A history of disordered eating: proceeding carefully Replied, post #70 · Wellbeing › Mental health · 22 Jan 2026 · 4 likes Reading this history of disordered eating thread as someone who came in with a fixed view: the third and seventh replies moved me and the confident ones did not.
Amylin receptor signalling and satiety — what changed since Replied, post #19 · Pharmacology › Receptor biology · 21 Jan 2026 · 13 likes Answering the question post #16 raises rather than the one it answers. Species differences in receptor pharmacology are substantial in this family, which is one reason…
A payment that went through twice: how it was resolved Replied, post #14 · Sourcing › Payments · 12 Jan 2026 · 4 likes Documentation and tax implications: payments you make for compounds might have implications for tax reporting depending on your jurisdiction. Keeping clear records…
Pharmacy supply in the UK and the questions you will be asked Replied, post #8 · Regional › UK & Ireland · 12 Jan 2026 · 22 likes I read post #4 twice before replying, because I had assumed the opposite. Compounding pharmacies: UK allows compounding under specific conditions when a licensed…
Non-inferiority margins: how they are chosen and how they are abused — a second dataset Replied, post #6 · Evidence › Trials · 11 Jan 2026 · 23 likes Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly random or could someone predict the next assignment),…
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #56 · Access › Pricing · 7 Jan 2026 · 0 likes Small methodological point on Price changes: repeating a measurement is cheap and resolves most of what is being argued about here at no cost to anyone.
Vomiting: when it is expected and when it is a reason to stop Replied, post #81 · Practice › Side effects · 29 Dec 2025 · 0 likes Adding the measurement that post #80 says would settle it. The published rates come from populations that were titrated on a defined schedule with clinical supervision.…
How to ask about something you suspect is a bad idea Replied, post #34 · Start Here › How to Ask · 14 Dec 2025 · 21 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either.
When your prescriber and the evidence disagree Started this topic · Clinical › Prescriber conversations · 13 Dec 2025 · 48 likes When your prescriber and the evidence disagree — that is the question, and I have not found it answered plainly anywhere I have looked. What changes if the standard…
Coming back to: Feature request: should a dose-equivalence tool exist at all? Replied, post #36 · Data & Tools › Calculators · 11 Dec 2025 · 9 likes On post #35 — agreed on the reasoning, with one qualification. A tool that refuses to give an answer when the result falls below one graduation is doing something…
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #3 · Sourcing › Red flags · 29 Nov 2025 · 29 likes I read the opening post twice before replying, because I had assumed the opposite. Safety documentation absent: a supplier that cannot provide information about…
Meeting a protein target on a suppressed appetite Replied, post #38 · Nutrition & Training › Protein & intake · 27 Nov 2025 · 2 likes Thank you — that answers what I came here to find out.
Reading U-100 graduations, with a conversion table Started this topic · Devices › Syringes & needles · 21 Nov 2025 · 3 likes Posting this under the heading it deserves: Reading U-100 graduations, with a conversion table Everything below is what sits behind that. A question about reading U-100…
Interpreting a result that disagrees with the supplier's certificate Replied, post #7 · Sourcing › Independent verification · 7 Nov 2025 · 10 likes Where two services agree with each other and with the declared figure, that is a genuinely strong result and it applies to that lot.
What pooling buys you and what it destroys Replied, post #55 · Evidence › Meta-analyses · 31 Oct 2025 · 0 likes That is a fair summary of where the discussion has got to.
Early satiety becoming a problem rather than a benefit Replied, post #4 · Practice › Side effects · 28 Oct 2025 · 0 likes Anti-emetics are frequently mentioned here and they are a prescribing decision. What the forum can tell you is that the underlying cause is usually mechanical rather…
Documentation that materially improves an appeal's chances Replied, post #39 · Access › Insurance & coverage · 25 Oct 2025 · 7 likes The denial letter is the specification for your appeal. It states a criterion, and the job is to demonstrate that the criterion is met in the letter's own language.
NHS criteria and how they are applied in practice — the long version Replied, post #6 · Regional › UK & Ireland · 19 Sep 2025 · 17 likes Two claims get bundled together under NHS criteria and they need separating. The descriptive one — this is what was observed — is usually well supported. The causal one…
Specificity, linearity, accuracy, precision, range, robustness — with real criteria — a… Replied, post #26 · Analytics › Method validation · 17 Sep 2025 · 2 likes Posting my Specificity numbers with the method attached so they can be discounted properly. Uncontrolled, unblinded, and collected by someone who wanted a particular…
Trial registration and comparing the protocol with the paper Replied, post #38 · Evidence › Trials · 14 Sep 2025 · 0 likes The first question about any trial is what it set out to estimate, not what it found. Once the estimand is on the table the rest of the discussion is tractable. Happy…
Insurance and replacement policies, compared — the long version Replied, post #14 · Sourcing › Logistics · 10 Sep 2025 · 0 likes What I want from this Insurance and replacement policies thread is the list of things that would need to be true for the claim to hold. If we can write that list, we…
Aggregated purity results across four services, with caveats — a second dataset Replied, post #89 · Data & Tools › Datasets · 9 Sep 2025 · 0 likes A codebook describing each field takes twenty minutes and is what makes the file usable by anyone but you. Most shared datasets here do not have one.
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #120 · Compounds › Tirzepatide · 7 Sep 2025 · 14 likes SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose at that time. It did not compare with semaglutide 2.4 mg, the highest approved dose.…
Second pass at: A history of disordered eating: proceeding carefully Replied, post #126 · Wellbeing › Mental health · 5 Sep 2025 · 3 likes Mood and anxiety: mood changes and anxiety are reported by some people. Baseline mental health status matters for risk. Someone with a history of depression should plan…
The nausea timeline across the first four weeks, with a tabulated log Replied, post #21 · Practice › Side effects · 28 Aug 2025 · 3 likes On post #19 — agreed on the reasoning, with one qualification. The published rates come from populations that were titrated on a defined schedule with clinical…
Why catalogue breadth is not evidence of anything — what changed since Replied, post #28 · Compounds › Other compounds · 26 Aug 2025 · 16 likes Coming back to post #27, because the follow-up matters more than the original answer. PT-141 was developed from the same family with a different receptor profile, and…
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #31 · Data & Tools › Calculators · 21 Jun 2025 · 3 likes Checked the titration planner refuses claim against the primary source this morning. It survives, with a narrower scope than the version quoted here. Posting the…
Promotion criteria, and the one that stops most nominations — the long version Replied, post #9 · Documentation › Doc review · 5 Jun 2025 · 23 likes Reviewing your own nomination is fine and is not sufficient. Somebody else has to read it for the process to mean anything.
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #119 · Sourcing › Independent verification · 19 May 2025 · 16 likes It does not extend to lots nobody has seen, it is not a recommendation, and it says nothing about anything other than what was measured.
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #84 · Compounds › Tirzepatide · 14 May 2025 · 0 likes Building on post #81 rather than restating it. SURPASS-2's comparator choice is the criticism that survives. Semaglutide 1.0 mg was the licensed diabetes dose at the…
Follow-up: Documentation that appears only after payment Replied, post #68 · Sourcing › Red flags · 11 May 2025 · 0 likes Reading back through, this was answered upthread and I missed it. My fault.
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #56 · Compounds › Secretagogues & GH axis · 5 May 2025 · 31 likes Research-use-only secretagogues are not approved for human use. That statement is doing real work in this subcategory, where the published evidence base is thinner than…
Shakes versus food: a pragmatic assessment — the long version Replied, post #14 · Nutrition & Training › Protein & intake · 2 May 2025 · 18 likes Post #11 answers the question as asked. The question underneath it is different. A methods point on Shakes versus food rather than a substantive one: if the comparison…
Counter-ion form: the field almost nobody reports — one year on Replied, post #103 · Analytics › COA interpretation · 20 Mar 2025 · 1 like Everything in post #99 holds. The case it does not cover is the one I have. Counter-ion form is crucial: peptides are isolated as salts, most often trifluoroacetate…
Charge states for a 4 kDa peptide, worked through Replied, post #136 · Analytics › Mass spectrometry · 17 Mar 2025 · 0 likes Worth separating two things that post #134 runs together. Practical note on charge states: write down what you expect before you look. The number of times I have found…
Research-use-only labelling: what it means and what it does not — the long version Replied, post #104 · Sourcing › Regulatory · 13 Mar 2025 · 0 likes Picking up post #101: that is the part I would want checked first. Adding a reference point for Research-use-only labelling. Mine is a single case, collected without…
Second pass at: Manufacturer assistance programmes and their eligibility rules Replied, post #13 · Access › Pricing · 11 Mar 2025 · 13 likes Post #12 is right about the mechanism and I think understates the practical bit. Insurance tier placement: a compound might be covered but on a higher tier (higher…
Talking to a therapist about this specifically — does this still hold? Replied, post #22 · Wellbeing › Mental health · 26 Feb 2025 · 32 likes Narrowing post #19, because the general version has more than one answer. Support and community: some people process weight change through community (online or…
When to suspect the method rather than the sample Replied, post #77 · Analytics › Method validation · 5 Feb 2025 · 15 likes A method that reports the same number for every lot is worth a second look. Real processes vary, and a total absence of variation is a statement about the measurement…
SURPASS-2 and the comparator dose question that will not go away Replied, post #104 · Compounds › Tirzepatide · 13 Jan 2025 · 5 likes SURPASS-2: I have looked for the primary source twice and failed twice. Either it does not exist or it is somewhere I do not know to look, and I would like to know which.
The topic list is dense — is that deliberate? Replied, post #75 · Meta › Site feedback · 31 Dec 2024 · 0 likes That would also be the fastest way for a new member to understand what R6 actually catches, which is narrower than people assume from the text. That is what the…
Tirzepatide storage and stability: what is published versus what is assumed — does this… Replied, post #16 · Compounds › Tirzepatide · 26 Dec 2024 · 1 like Reading back through, this was answered upthread and I missed it. My fault.
Why "any advice?" is the least effective ending for a post Replied, post #114 · Start Here › How to Ask · 6 Dec 2024 · 6 likes Seconded. It reads as careful rather than confident, which is the right register.
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #48 · Evidence › Journal club · 2 Dec 2024 · 15 likes SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the cardiovascular evidence to the oral formulation. Note that oral bioavailability is lower…
UK access routes, dated and sourced — a second dataset Replied, post #4 · Regional › UK & Ireland · 3 Nov 2024 · 13 likes Members outside these two jurisdictions reading this thread should note that none of it transfers, including the parts that sound general. Not the whole picture, but…
High-resolution MS on aggregates and what it can see — one year on Replied, post #51 · Analytics › Mass spectrometry · 20 Aug 2024 · 11 likes My understanding of High-resolution is a few years old and may have been superseded. If it has been, I would genuinely like to know rather than keep repeating it.
Second pass at: Journal club: LEADER as the historical anchor Replied, post #70 · Evidence › Journal club · 27 Jul 2024 · 0 likes On post #68 — agreed on the reasoning, with one qualification. Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded…
Follow-up: Conditions that change the calculus rather than forbidding it Replied, post #3 · Safety › Contraindications · 12 Jul 2024 · 0 likes Where a condition appears as a warning rather than a contraindication, the decision is a clinical one rather than a prohibition.
The mass-error checker and its intended scope Replied, post #62 · Data & Tools › Calculators · 20 Jun 2024 · 0 likes On mass-error checker I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and conflating them is how…